Aldrin Yim has always maintained a dual-interest in both computer science and medical research. As an experienced bioinformatician, his major findings include the discovery of a major allergen class (designated as Group 24th major allergen by WHO/IUIS Allergen Nomenclature subcommittee) through a multi-omic approach analysis of house Dust Mite (JACI, 2015), as well as the identification of a salt-tolerance gene in soybean through large scale genomic analysis (Nat. Comm., 2014). Aldrin has a strong understanding in big data analytics and visualization, and his latest research focuses on single nucleus transcriptome profiling of the peripheral nervous system (PNS). Apart from scientific research, Aldrin is also the founding CEO of Codex Genetics Limited (HK), which provides personalized disease treatment to patients with cancers and neurological disorders in collaboration with hospitals in Hong Kong.
